About us

Metrasens is the world’s leading provider of advanced magnetic detection technologies.

Our innovative products are designed to address deficiencies in conventional screening methods, to make us all safer and more secure. Our mission is to take great science from the laboratory and use it to create revolutionary, award-winning products which meet the real needs of our customers.

Metrasens’ core technologies have an extremely wide range of potential applications. Our growth to date has been achieved through the ability of our team to clearly identify and prioritize the areas in which our technology can make the most significant impact, solving acute problems. We embody our technology in solutions that are easy to adopt and simple to use.

Innovation is at the core of everything we do – from research and development, through to customer service and training. Metrasens products are already making a real impact in a range of sectors, from medical-imaging departments to correctional facilities, and we’re just at the start of our journey.

Making a real difference

Metrasens has grown rapidly to become a dynamic international business, and the acknowledged leader in our chosen markets. With a Technology Center and manufacturing facility in the UK, a North American sales and customer service hub in Chicago, and a global network of distributors. Metrasens’ products are making a difference for our customers in over 40 countries.

Metrasens adds value to our customers not just through our technology, but also through the delivery of carefully targeted training and education, accelerating adoption and maximizing efficacy.

Our developments continue to enable new customers, working in increasingly complex environments, to achieve higher levels of safety and security. From protecting secure data-facilities, to providing non-disruptive threat detection in high-footfall locations such as government buildings, religious gatherings, and transport facilities.


Metrasens founded in 2005

Metrasens Founded

Metrasens is founded in Malvern, UK by Dr Simon Goodyear, Dr Mark Keene and Matt Wooliscroft. With decades of collective experience in magnetic detection technologies the team begin developing innovative products that improve safety and security around the world.

Saving a life in 2007

Ferroguard saves a life during a demonstration

An incident at a UK hospital, where Metrasens was giving an early demonstration of our Ferroguard MRI safety system, results in a life being saved.

A nine-year-old girl taken into the MRI for a head scan, complained of extreme pain around her nose before the test started. The Ferroguard system detects a strong ferrous signal from the girl. As a result, an x-ray is requested to investigate. This reveals the girl had two magnets, from a toy, stuck up her nose. Attraction of the magnets would have been likely to have caused significant injury, or worse, if the MRI scan had been performed.

iAward Winners 2009

Winners of inaugural iAward

Metrasens wins the inaugural iAward for Cross Application of Technology. The UK government award was launched to celebrate the best of British science, innovation and technology and is supported by a range of leading business figures.

Octopus investments logo

Octopus makes first investment into Metrasens

Octopus Ventures, one of Europe’s largest venture capital teams, invest in Metrasens to help us further develop and enhance our product range in the medical and security markets.

Ferroguard Screener

Introduction of Ferroguard Screener

Metrasens launch Ferroguard Screener, the world’s first – and still the most sensitive – whole-body ferromagnetic detection system for MRI safety, detecting risk items that other systems just miss.

New premises opened

New expanded UK facilities open as rapid growth continues

Our world-leading Cellsense® product is launched and quickly adopted by prisons across the USA and beyond as they fight against the smuggling and use of mobile phones and other contraband items. Due to our fast-growth we move to new expanded facilities in both Malvern, UK and Lisle, Illinois, USA.

Cellsense poles

Cellsense® Plus launched

Cellsense® Plus is launched, providing corrections facilities with superior an unrivalled contraband and cell phone detector. The new product incorporates a more rugged design and builds on the original Cellsense product which, by 2015, is already used in 38 countries. 2015 also sees us win an innovation award from the Institute of Physics.

Mental health products launched

Metrasens enters mental health market

An unfortunate death at a NHS mental health facility led Metrasens to develop Proscreen 200™, providing behavioral health and mental health facilities with the capability to perform an unobtrusive full body screening.

2016 also marks the launch of the MRI Safety Manager™ module as part of the Ferroguard Assure system – revolutionising FMDS for MRI Safety. For the first time MRI facilities are provided with simple, comprehensive analytics and reporting enabling data-driven management of safe working practices.

Metrasens' team celebrate Queen's Award win

Winners of the queen's award for enterprise

We’re honoured to have won The Queen’s Award for Enterprise in the category of International trade in 2017. The UK’s premier business award is recognition for our international growth with revenue growing by over 400% over the past 6 years and 95% of this coming from international markets.

Metrasens Times fast track 100

Named among Britain’s fastest growing companies

Metrasens appear in the 4th annual Sunday Times Lloyds SME Export Track 100 league table which ranks Britain’s companies with the fastest-growing international sales.

We also won the prestigious Queen’s Award For Enterprise for the second consecutive year, this time in the category of Innovation for our unique ferromagnetic detection systems.


Dr Simon Goodyear

CEO and co-founder

Martin Coleman


Dr Mark Keene


Colin Robertson

Senior Vice President, Sales & Marketing

James Viscardi

Vice President, Global Security


Vice President, Healthcare Safety


Octopus Ventures logo
C5 Capital logo
Advantage Business Angels logo